前往化源商城

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one

更新时间：2025-08-22 18:51:02

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式	常用名	5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one	英文名	5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one
	CAS号	1229937-09-0	分子量	375.37700
	密度	N/A	沸点	N/A
	分子式	C₂₁H₁₇N₃O₄	熔点	N/A
	MSDS	N/A	闪点	N/A

英文名	5-[4,5-Bis(benzyloxy)-2-pyridinyl]-1,3,4-oxadiazol-2(5H)-one

分子式	C₂₁H₁₇N₃O₄
分子量	375.37700
精确质量	375.12200
PSA	82.37000
LogP	3.71180
InChIKey	SEROJOMPCMRBRI-UHFFFAOYSA-N
SMILES	O=c1[nH]nc(-c2cc(OCc3ccccc3)c(OCc3ccccc3)cn2)o1

4,5-bis(benzyloxy)pyridine-2-carbohydrazide结构式

4,5-bis(benzylo...

1229937-08-9

N,N'-羰基二咪唑(CDI)结构式

N,N'-羰基二咪唑(CDI)

530-62-1

~90%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献：Pfizer Inc Patent: US2010/160281 A1, 2010 ; Location in patent: Page/Page column 13-14 ; US 20100160281 A1

bis-(1h-imidazol-2-yl)-methanone结构式

bis-(1h-imidazo...

64269-79-0

4,5-bis(benzyloxy)pyridine-2-carbohydrazide结构式

4,5-bis(benzylo...

1229937-08-9

~92%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献：Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

曲酸结构式

曲酸

501-30-4

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献：Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

5-(苄氧基-2-(羟甲基)-4H-吡喃-4-酮结构式

5-(苄氧基-2-(羟甲基)-...

15771-06-9

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献：Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

4,5-二苄氧基吡啶甲酸苄酯结构式

4,5-二苄氧基吡啶甲酸苄酯

112334-42-6

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献：Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

5-苄氧基-4-氧代-4H-吡喃-2-羧酸结构式

5-苄氧基-4-氧代-4H-吡...

1219-33-6

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献：Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

氯化苄结构式

氯化苄

100-44-7

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献：Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

1,4-dihydro-4-oxo-5-(phenylmethoxy)-2-pyridinecarboxylic acid结构式

1,4-dihydro-4-o...

742026-59-1

~%

5-(4,5-bis(benzyloxy)pyridin-2-yl)-1,3,4-oxadiazol-2(5H)-one结构式

5-(4,5-bis(benz...

1229937-09-0

文献：Flanagan, Mark E.; Brickner, Steven J.; Lall, Manjinder; Casavant, Jeffrey; Deschenes, Laura; Finegan, Steven M.; George, David M.; Granskog, Karl; Hardink, Joel R.; Huband, Michael D.; Hoang, Thuy; Lamb, Lucinda; Marra, Andrea; Mitton-Fry, Mark; Mueller, John P.; Mullins, Lisa M.; Noe, Mark C.; O'Donnell, John P.; Pattavina, David; Penzien, Joseph B.; Schuff, Brandon P.; Sun, Jianmin; Whipple, David A.; Young, Jennifer; Gootz, Thomas D. ACS Medicinal Chemistry Letters, 2011 , vol. 2, # 5 p. 385 - 390

本网页内容来自不同专业数据源，如对内容有疑义，欢迎联系service1@chemsrc.com。